After the cure: management of HCV after achievement of SVR.
Publication/Presentation Date
12-1-2013
Abstract
Co-infection with HIV and HCV is associated with accelerated progression of liver disease and increased complications compared with HCV infection alone. Treatment of HCV and achievement of a sustained virologic response (SVR) can improve outcomes in these patients. Even after clearance of the hepatitis C virus, however, patients remain at risk, albeit diminished, for the complications of chronic liver disease. As such, longitudinal monitoring of treated patients remains important for clinicians caring for this population. This article summarizes the benefits and persistent risks after attaining SVR. It reviews the natural history of fibrosis and addresses the monitoring and management of progressive liver disease.
Volume
10
Issue
4
First Page
428
Last Page
435
ISSN
1548-3576
Published In/Presented At
Zator, Z. A., & Chung, R. T. (2013). After the cure: management of HCV after achievement of SVR. Current HIV/AIDS reports, 10(4), 428–435. https://doi.org/10.1007/s11904-013-0181-9
Disciplines
Medicine and Health Sciences
PubMedID
24218111
Department(s)
Department of Medicine
Document Type
Article